The proposal would let pharmacists supply schools with federally approved epinephrine devices containing premeasured doses, with a prescription issued in the school's name.
Schools could choose to stock prescribed epinephrine devices with premeasured doses. Nurses and trained school workers could use them for anyone showing signs of a severe allergic reaction.
Students could carry and use prescribed epinephrine devices after meeting school medication rules. They would need to show they can use them safely, with parental permission and signed liability paperwork.
Pharmacists could supply schools with standard-dose and child-dose epinephrine devices. Public and accredited private elementary and secondary schools would be covered. Emergency use could occur at school, on school property, or at a school-sponsored event. Devices would need federal Food and Drug Administration approval and a premeasured dose of epinephrine. A doctor or another legally authorized prescriber would have to review the school's emergency medicine policies and prescribe the medicine in the school's name. A school nurse or trained, designated school worker could give it when they reasonably believe someone shows signs of a severe allergic reaction. The bill called for these provisions to take effect after publication in the statute book, but it died in committee and did not become law.
Students could carry and use prescribed epinephrine delivery systems under school medication rules. The rules would cover students in kindergarten through grade 12. Permission would apply wherever the school district supervises the student. Students would need a provider's written medicine instructions and treatment plan, and they would have to show they can use the medicine and device correctly. Parents would have to renew permission each year and sign paperwork releasing the school from related claims and agreeing to protect it from those claims. Schools could set additional requirements and conditions for withdrawing permission.
No hearings or votes scheduled.